Delve into the field of PARP inhibitors, a class that has gained traction in ovarian, breast, and prostate cancers.

The Phase I segment will enrol up to 30 patients with recurrent and progressive GBM or other high-grade gliomas.

The increase in median overall survival among women treated with IMNN-001 in the OVATION 2 trial rose from the previously reported 11.1 months to 14.7 months following final data analysis Patients ...

New analytical methods developed at Baylor College of Medicine and collaborating institutions have increased our ...

Working on human pus in a medieval castle, Miescher discovered a substance that would eventually unlock our understanding of ...

Scientists have just discovered an entirely new way that DNA can be synthesized. The business of constructing DNA ...

Joslin researchers identify a 3D DNA switch that controls brown fat’s calorie‑burning power, opening new paths to fight ...

View all available purchase options and get full access to this article. The following represents disclosure information provided by authors of this manuscript. All relationships are considered ...

The abundance of viral DNA was measured in DNA sequenced from blood and saliva samples in biobanks, revealing strong ...